Your browser doesn't support javascript.
loading
Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer.
Xu, Jia-Li; Wang, Xin-Zhu; Jiang, Hu-Ning; Chen, Yi; Wang, Rong; Shu, Yong-Qian.
Afiliação
  • Xu JL; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Wang XZ; First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Jiang HN; First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Chen Y; First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Wang R; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Shu YQ; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Chin Med J (Engl) ; 133(20): 2495-2497, 2020 Oct 20.
Article em En | MEDLINE | ID: mdl-32941237
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article